Hormone-free option
Safety focused
Women’s Health Clinic FAQ
Does the intimate polynucleotide procedure hurt?
Intimate polynucleotides are non-hormonal biostimulatory treatments used in some clinics for vulvovaginal tissue quality. The important first step is confirming the symptom cause, not choosing an injectable by name.
Direct answer
The intimate polynucleotide procedure usually involves small superficial injections, so some stinging, pressure, pinching or tenderness can occur. Topical anaesthetic is commonly used to improve comfort, and the clinician should pause if pain feels severe or unexpected. Mild soreness, swelling or bruising can happen afterwards, but escalating pain, spreading redness, pus, fever or unusual bleeding needs prompt advice. Needle anxiety and consent should be handled carefully before treatment starts.
Your clinician should review symptoms, medical history, allergies, medicines, cancer history where relevant, alternatives, expected benefits, limitations and aftercare before deciding whether treatment fits.
Educational only. Suitability must be confirmed after consultation and assessment. Results vary. Not a cure.
At a glance
These are the main points to understand before deciding whether intimate polynucleotides are suitable.
Polynucleotides at a glance
Non-hormonal biostimulation
Origin
Polynucleotides (PN) are highly purified bioactive DNA fragments primarily extracted from trout or salmon sperm cells.
Mechanism
They act as biological messengers that stimulate fibroblast cells to increase the natural production of collagen and elastin, while meaningfully.
Intimate Application
PN therapy may support symptoms of Genitourinary Syndrome of Menopause (GSM) and vulvovaginal atrophy (VVA), including severe dryness, itching, laxity.
Non-Hormonal
It serves as a powerful regenerative alternative for women who cannot, or choose not to, use topical or systemic Hormone.
Important safety note
Safety Profile: Polynucleotides possess an reported safety profile. The rigorous purification process strips away all proteins, rendering the risk of an allergic (immunogenic) response virtually zero.
Allergy
Evidence
Aftercare
Alternatives
Detailed answer
What it may feel like
Patients may feel stinging, pressure, warmth or tenderness despite numbing cream.
Pain should stay proportionate
Severe pain should pause the procedure and trigger reassessment rather than being normalised.
Evidence
Symptoms
Alternatives
What it means
Bio-regeneration vs. Volumization: Unlike traditional hyaluronic acid (HA) dermal fillers, polynucleotides do not simply add artificial volume. They are bio-stimulators that trigger true cellular repair and structural tissue regeneration.
Why symptoms matter
Synergistic Formulations: Advanced intimate PN formulations (such as NewGyn) often combine polynucleotides with hyaluronic acid and mannitol to simultaneously stimulate repair, support immediate hydration, and protect the HA from rapid.
Evidence limits
Evidence is encouraging in selected areas, but intimate-use claims should remain cautious and assessment-led.
Treatment fit
Setting: Procedures are performed in an outpatient clinical setting by a qualified medical aesthetic practitioner, doctor, or specialised gynaecologist.
What this means in practice
Setting: Procedures are performed in an outpatient clinical setting by a qualified medical aesthetic practitioner, doctor, or specialised gynaecologist.
Session Duration: The clinical appointment typically lasts 30 to 45 minutes.
Patient safety
Why diagnosis comes first
Many intimate symptoms overlap. The right treatment depends on whether the issue is GSM, infection, vulval skin disease, scarring, pelvic-floor guarding, medication effect or another cause.
It checks the cause
Polynucleotides are biostimulatory rather than volumising, so the aim is gradual tissue-quality support.
It protects safety
Comfort measures do not remove the need to screen for infection, allergy, bleeding and severe pain.
It reviews alternatives
Moisturisers, lubricants, local ooestrogen, pelvic-floor care or specialist review may be more appropriate first.
It sets expectations
Polynucleotides are gradual tissue-support treatments, not instant resolves or promised outcomes.
Non-hormonal does not mean automatic
A hormone-free option may still be unsuitable if there is infection, unexplained bleeding, pregnancy, recent surgery, severe fish allergy or unclear pelvic pain.
Good care explains product source, treatment route, alternatives, limits, aftercare and when another medical pathway is safer.
Considerations
What to consider
Treatment planning should include diagnosis, symptom pattern, allergy risk, medicines, consent, realistic timelines and aftercare.
Consultation priorities
A consultation should review symptoms, medical history, fish allergy, infection risk, bleeding risk, pregnancy status, expectations and alternatives.
Consent
Aftercare
Review
Before treatment
Preparation: Patients are advised to shave or wax the day before, attend well-hydrated, and wear white cotton underwear for comfort.
During care
Pre-Treatment Restrictions: Avoid alcohol, NSAIDs (like aspirin or ibuprofen), fish oils, and strenuous exercise 24 hours prior to mitigate the risk of excessive bruising.
Aftercare
The Procedure: After clinical assessment and skin sterilization, a topical anaesthetic is applied for 20-30 minutes. The clinician then administers multiple micro-injections across the vulvovaginal area.
When to reassess
If symptoms persist, worsen or do not match expectations, reassessment is safer than repeating treatment automatically.
Practical expectations
Session Duration: The clinical appointment typically lasts 30 to 45 minutes.
Costs and treatment plans should be confirmed before booking; do not rely on generic package claims.
Common concerns and myths
Common misconceptions
Clear patient information should correct over-simple claims and keep expectations realistic.
Myth: polynucleotides are fillers
Reality: they are biostimulatory DNA fragments used for gradual tissue-quality support, not instant volume.
Myth: hormone-free means suitable for everyone
Reality: fish allergy, infection, bleeding, pregnancy, recent surgery and unclear pain can make treatment unsuitable.
Myth: results are promised
Reality: response varies and should be reviewed before repeating treatment.
Evidence and limits
Mechanism-of-action language should not be treated as proof of a predictable result.
Alternatives still matter
Moisturisers, local hormonal care, pelvic-floor physiotherapy, infection treatment or specialist review may be better for some patients.
Safety checklist
Safety checklist
Use these questions to decide whether treatment should be discussed, delayed or redirected.
Has the cause been assessed?
Symptoms should be reviewed in context before selecting an injectable treatment.
Are red flags absent?
Active infection, unexplained bleeding, severe pain or new vulval changes should be checked first.
Are alternatives clear?
Ask what conservative, hormonal, pelvic-floor or specialist options may be more appropriate.
Is follow-up planned?
The clinic should explain aftercare, review timing and when to seek help.
Reassuring signs
Proceeding is more reasonable when diagnosis is clear, goals are realistic, red flags are absent and aftercare is understood.
No red flags
Review plan
Reasons to pause
Pause treatment for active infection, unexplained bleeding, pregnancy, severe fish allergy, recent pelvic surgery, severe pain or changing vulval skin.
Bleeding
Infection
When to escalate
When to seek medical help
Some symptoms should be assessed before any elective intimate treatment. Use NHS 111 online
Allergy symptoms
Swelling of the lips, tongue or face, breathing difficulty, widespread hives, faintness or collapse needs urgent help.
Bleeding or new skin change
New post-menopausal bleeding, ulcers, changing white plaques, unusual discharge or visible blood in urine should be assessed.
Infection signs
Fever, pus, spreading redness, worsening swelling or feeling unwell after a procedure needs prompt advice.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain or breathing difficulty.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
Regulatory resources
Authoritative resources
These sources support assessment-led, evidence-aware patient information and help separate clinical care from promotional claims.
PubMed: PN/HA intradermal treatment for vulvovaginal atrophy
This pilot study is directly relevant to PN/HA use in vulvovaginal atrophy and supports cautious evidence-aware discussion.
NICE menopause recommendations
NICE provides UK guidance for GSM, vaginal ooestrogen, non-hormonal care and cancer-history decision-making.
NHS guidance on allergies
NHS allergy guidance supports screening and urgent escalation language for fish-derived products.
Next step
Book a clinical consultation
A consultation can confirm whether intimate polynucleotides may be suitable, whether another pathway should come first, and what realistic outcomes, risks and aftercare would look like.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 47 imported records. Additional reviewed material included peer-reviewed clinical papers, evidence reviews, clinical trial records; duplicate, low-relevance and non-clinical records were removed before display.
Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.
